Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings.
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: The role of kallikrein-kinin system.
Investigation of cytocrom c oxidase gene subunits expression on the Multiple sclerosis.
Effective management of intractable neuropathic pain using an intrathecal morphine pump in a patient with acute transverse myelitis.
Meta-Analysis of the Correlation Between Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis.
[Clinical epidemiology of multiple sclerosis in Moscow. Discriptive epidemiology in population of one region of Moscow.]
Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
Literature Commentary.
Fiber density index in the evaluation of the spinal cord in patients with multiple sclerosis.
Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.
Induced brain plasticity after a facilitation programme for autobiographical memory in multiple sclerosis: a preliminary study.
What is the true clinicopathologic spectrum of neuromyelitis optica?-Reply.
Steps Per Day Among Persons With Multiple Sclerosis: Variation by Demographic, Clinical, and Device Characteristics.
[Clinical features and prognosis of pediatric multiple sclerosis].
The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
Switching and escalating therapy in long-lasting multiple sclerosis: not always necessary.
Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases.
Redox processes in neurodegenerative disease involving reactive oxygen species.
Fatigue, depression, and physical impairment in multiple sclerosis.
The relationship of age, function, and psychological distress in multiple sclerosis.
Recent imaging advances in neurology.
Time-Lapse Imaging of Glial-Axonal Interactions.
Central Autonomic Dysfunction Delays Recovery of Fingolimod Induced Heart Rate Slowing.
Pages
« first
‹ previous
…
380
381
382
383
384
385
386
387
388
…
next ›
last »